LAVA THERAPEUTICS NV's ticker is LVTX and the CUSIP is N51517105. A total of 17 filers reported holding LAVA THERAPEUTICS NV in Q2 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $15,141 | -26.9% | 10,300 | +1.0% | 0.00% | – |
| Q2 2023 | $20,706 | +40.2% | 10,200 | +14.6% | 0.00% | – |
| Q1 2023 | $14,774 | -39.6% | 8,900 | +27.3% | 0.00% | – |
| Q4 2022 | $24,469 | +6.4% | 6,991 | +39.8% | 0.00% | – |
| Q3 2022 | $23,000 | +35.3% | 5,000 | -12.3% | 0.00% | – |
| Q2 2022 | $17,000 | +41.7% | 5,700 | +103.6% | 0.00% | – |
| Q1 2022 | $12,000 | -50.0% | 2,800 | -35.3% | 0.00% | – |
| Q4 2021 | $24,000 | – | 4,325 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SILVERARC CAPITAL MANAGEMENT, LLC | 610,809 | $2,791,000 | 0.94% |
| Novo Holdings A/S | 3,327,312 | $15,206,000 | 0.72% |
| Redmile Group, LLC | 2,816,196 | $12,870,000 | 0.50% |
| Alpha Wave Global, LP | 121,193 | $554,000 | 0.06% |
| Artal Group S.A. | 200,000 | $914,000 | 0.04% |
| Cannell Capital | 17,955 | $82,000 | 0.02% |
| UBS OCONNOR LLC | 75,000 | $343,000,000 | 0.01% |
| AXA S.A. | 457,342 | $2,090,026 | 0.00% |
| TSFG, LLC | 400 | $2,000 | 0.00% |
| OSAIC HOLDINGS, INC. | 48 | $0 | 0.00% |